Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,311 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Serum NY-ESO-1 antibody as a predictive biomarker for postoperative recurrence of gastric cancer: a multicenter prospective observational study.
Saito T, Kurokawa Y, Fujitani K, Kawabata R, Takeno A, Mikami J, Endo S, Matsuyama J, Akamaru Y, Hirota M, Kishi K, Urakawa S, Yamamoto K, Tanaka K, Takahashi T, Oka M, Wada H, Eguchi H, Doki Y. Saito T, et al. Among authors: oka m. Br J Cancer. 2024 Apr;130(7):1157-1165. doi: 10.1038/s41416-023-02540-3. Epub 2024 Feb 7. Br J Cancer. 2024. PMID: 38326601 Free PMC article.
Induction chemotherapy with cisplatin, vinorelbine, and mitomycin-C followed by surgery for patients with pathologic N2 non-small-cell lung cancer.
Akamine S, Nakamura Y, Oka T, Soda H, Taniguchi H, Fukuda M, Minami H, Nagashima S, Ashizawa K, Goya T, Oka M, Kohno S, Tagawa T, Nagayasu T; Nagasaki Thoracic Oncology Group. Akamine S, et al. Among authors: oka t, oka m. Clin Lung Cancer. 2008 Jan;9(1):44-50. doi: 10.3816/clc.2008.n.008. Clin Lung Cancer. 2008. PMID: 18282358
Successful treatment with bortezomib for refractory cryoglobulinemic vasculitis triggered by ischemic non-obstructive coronary artery disease.
Ohta Y, Tsuchiya T, Oka M, Tachibana M, Kondo Y, Fukushima K, Matsuno S, Yamanaka N, Suzuki N, Komatsu A, Rokutan H, Yumura W, Arai T, Ishigami A, Itabashi M, Takei T. Ohta Y, et al. Among authors: oka m. CEN Case Rep. 2025 Jan 6. doi: 10.1007/s13730-024-00963-2. Online ahead of print. CEN Case Rep. 2025. PMID: 39760978 Free article.
Preliminary evidence of renal function improvement in chronic progressive kidney disease using autologous CD34+ cell therapy: A clinical trial.
Ohtake T, Sato T, Tsukiyama T, Muraoka S, Mitomo A, Maruyama H, Yamano M, Mochida Y, Ishioka K, Oka M, Moriya H, Hidaka S, Masuda H, Asahara T, Kobayashi S. Ohtake T, et al. Among authors: oka m. World J Stem Cells. 2024 Dec 26;16(12):1012-1021. doi: 10.4252/wjsc.v16.i12.1012. World J Stem Cells. 2024. PMID: 39734483 Free PMC article. Clinical Trial.
2,311 results